Diabetes and COVID-19

Lieferzeit: Lieferbar innerhalb 14 Tagen

149,79 €

inkl. 7 % MwSt. zzgl. Versandkosten

Considerations and Clinical Management, Contemporary Endocrinology

ISBN: 3031285352
ISBN 13: 9783031285356
Herausgeber: Alyson K Myers
Verlag: Springer Verlag GmbH
Umfang: xviii, 219 S., 2 s/w Illustr., 21 farbige Illustr., 219 p. 23 illus., 21 illus. in color.
Erscheinungsdatum: 11.06.2023
Auflage: 1/2023
Produktform: Gebunden/Hardback
Einband: GEB

Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology, infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine. Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions.

Artikelnummer: 8601906 Kategorie:

Beschreibung

Autorenporträt

Alyson K. Myers, MD, Division of Endocrinology, Department of Medicine, Montefiore Einstein, Bronx, NY

Das könnte Ihnen auch gefallen …